Condition code |
Definition |
---|---|
71 |
Full care in unit or transient |
72 |
Self-care in unit |
73 |
Training |
74 |
Home |
76 |
Backup in-facility dialysis |
Condition code |
Definition |
---|---|
59 |
Non-primary ESRD facility |
70 |
Self-administered anemia management drug [Erythropoietin (EPO)] |
80 |
ESRD beneficiary receiving home dialysis in nursing facilities, including skilled nursing facilities (report along with condition code 74) |
84 |
Acute kidney injury (AKI) on a monthly basis |
86 |
Additional hemodialysis treatments with medical justification |
87 |
Self-care retraining |
H3 |
Gastrointestinal (GI) bleeding |
H4 |
Pneumonia |
H5 |
Pericarditis |
Value Code |
Definition |
---|---|
48 |
Hemoglobin reading |
49 |
Hematocrit reading |
A8 |
Weight of patient (in kilograms) |
A9 |
Height of patient (in centimeters) |
D5 |
Result of last Kt/V reading |
Revenue code |
Definition |
---|---|
0634 |
EPO, less than 10,000 units administered |
0635 |
EPO, 10,000 units or more administered |
0636 |
Darbepoetin Alfa and drugs requiring specific information |
082X |
Hemodialysis |
083X |
Peritoneal dialysis |
084X |
Continuous Ambulatory Peritoneal Dialysis (CAPD) |
085X |
Continuous Cycling Peritoneal Dialysis (CCPD) |
0881 |
Ultrafiltration, performed separately from dialysis treatment |
HCPCS |
Definition |
Frequency |
---|---|---|
90999 |
Unlisted dialysis procedure, inpatient or outpatient |
Billable three times per week; 13 times in 30 days and 14 times in 31 days |
J0882 |
Injection, Darbepoetin Alfa, 1mcg (for ESRD on dialysis) (Aranesp) |
Maximum number of administrations of Aranesp for a billing cycle is five times in 30 or 31 days |
Q4081 |
Injection, Epoetin alfa, 100 units (for ESRD on dialysis) |
Maximum number of administrations of EPO for a billing cycle is 13 times in 30 days and 14 times in 31 days |
Modifiers |
Definition |
---|---|
AX |
Item furnished in conjunction with dialysis services |
AY |
Item or service furnished to an ESRD patient that is not for the treatment of ESRD |
CG |
Policy criteria applies (report with revenue codes 0821 or 0881 and HCPCS 90999 when billing dialysis treatments in excess of the 13 or 14 monthly allowable treatments) |
ED |
Hematocrit greater than 39.0% or hemoglobin greater than 13.0g/dL for 3 or more consecutive billing cycles immediately prior to and including the current billing cycle |
EE |
Hematocrit greater than 39.0% or hemoglobin greater than 13.0g/dL for less than 3 consecutive billing cycles immediately prior to and including the current billing cycle |
EJ |
Subsequent claims for a defined course of therapy, e.g., EPO, sodium hyaluronate, infliximab |
EM |
Emergency reserve supply |
ET |
Emergency services |
GS |
Dosage of EPO or Aranesp has been reduced and maintained in response to hematocrit or hemoglobin level |
G1 |
Most recent Urea Reduction Ratio (URR) of less than 60% |
G2 |
Most recent URR of 60% to 64.9% |
G3 |
Most recent URR of 65% to 69.9% |
G4 |
Most recent URR of 70% to 74.9% |
G5 |
Most recent URR of 75% or greater |
G6 |
ESRD patient for whom less than seven dialysis sessions have been provided in a month |
JA |
Administered intravenous |
JB |
Administered subcutaneous |
JW |
Drug amount discarded/not administered |
Q3 |
Kidney donor services |
UJ |
Services provided at night |
V5 |
Any vascular catheter (alone or with any other vascular access) Note: ESRD claims for hemodialysis must indicate the type of vascular access used for the delivery of the hemodialysis at the last hemodialysis session of the month. A code is required to be reported on the latest line-item date of service billing for hemodialysis revenue code 0821. It may be reported on all revenue code 0821 lines at the discretion of the provider. |
V6 |
Arteriovenous graft (or other vascular access, not including a vascular catheter) Note: ESRD claims for hemodialysis must indicate the type of vascular access used for the delivery of the hemodialysis at the last hemodialysis session of the month. A code is required to be reported on the latest line-item date of service billing for hemodialysis revenue code 0821. It may be reported on all revenue code 0821 lines at the discretion of the provider. |
V7 |
Arteriovenous fistula only (in use with two needles) Note: ESRD claims for hemodialysis must indicate the type of vascular access used for the delivery of the hemodialysis at the last hemodialysis session of the month. A code is required to be reported on the latest line-item date of service billing for hemodialysis revenue code 0821. It may be reported on all revenue code 0821 lines at the discretion of the provider. |
Revenue code |
Frequency |
Condition code |
Value code |
Monthly limit |
---|---|---|---|---|
0634- EPO<10,000 or 0635- EPO>10,000 |
Three times per week |
N/A |
48 and/or 49 |
13 times in 30 days/ 14 times in 31 days |
0636- Darbepoetin Alfa (DPO) (Aranesp) |
N/A |
N/A |
48 and/or 49 |
Five times per month |
082X- Hemodialysis |
Three times per week |
71, 72, 73, 74, 76 |
A8, A9, D5 |
13 times in 30 days/ 14 times in 31 days |
083X- Peritoneal dialysis |
Three times per week |
71, 72, 73, 74, 76 |
A8, A9, D5 |
13 times in 30 days/ 14 times in 31 days |
084X- CAPD |
Daily |
73 or 74 |
A8, A9, D5 |
13 times in 30 days/ 14 times in 31 days |
085X- CCPD |
Daily |
73 or 74 |
A8, A9, D5 |
13 times in 30 days/ 14 times in 31 days |